Familial Mediterranean fever – Treatment

Attacks are self-limiting, and require analgesia and non-steroidal anti-inflammatory drugs (such as diclofenac). Colchicine, a drug otherwise mainly used in gout, decreases attack frequency in FMF patients.

Attacks are self-limiting, and require analgesia and non-steroidal anti-inflammatory drugs (such as diclofenac).

Colchicine, a drug otherwise mainly used in gout, decreases attack frequency in FMF patients. The exact way in which colchicine suppresses attacks is unclear. While this agent is not without side effects (such as abdominal pain and muscle pains), it may markedly improve quality of life in patients. The dosage is typically 1–2& mg a day. Development of amyloidosis is delayed with colchicine treatment. Interferon is being studied as a therapeutic modality. Some advise discontinuation of colchicine before and during pregnancy, but the data is inconsistent and others feel that it is safe to take colchicine during pregnancy.


Adapted from the Wikipedia article Familial Mediterranean fever, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki








Related Articles

Familial Mediterranean FeverDue to their origin in the Mediterranean basin, there is a higher incidence of certain hereditary diseases and inherited disorders in Sephardi Jews. H...
Familial Mediterranean FeverAA amyloidosis is a form of amyloidosis associated with serum amyloid A protein (SAA), an acute-phase protein. It causes reactive systemic amyloidosis...
A New York allergist, Dr Sheppard Siegal, first described the attacks of peritonitis in 1945; he termed this “benign paroxysmal peritonitis̶...
Familial Mediterranean FeverFamilial Mediterranean fever: More than 80 ”MEFV” mutations that cause familial Mediterranean fever have been identified. A few mutations ...
Familial Mediterranean FeverAttacks There are seven types of attacks. Ninety percent of all patients have their first attacks before they are 18 years old. All develop over 2&nda...